Amylyx Pharmaceuticals (AMLX) Return on Assets: 2022-2025
Historic Return on Assets for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Sep 2025 value amounting to -0.53%.
- Amylyx Pharmaceuticals' Return on Assets rose 36.00% to -0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.53%, marking a year-over-year increase of 36.00%. This contributed to the annual value of -0.85% for FY2024, which is 96.00% down from last year.
- As of Q3 2025, Amylyx Pharmaceuticals' Return on Assets stood at -0.53%, which was up 40.88% from -0.90% recorded in Q2 2025.
- Over the past 5 years, Amylyx Pharmaceuticals' Return on Assets peaked at 0.10% during Q4 2023, and registered a low of -1.36% during Q4 2024.
- In the last 3 years, Amylyx Pharmaceuticals' Return on Assets had a median value of -0.44% in 2024 and averaged -0.53%.
- Per our database at Business Quant, Amylyx Pharmaceuticals' Return on Assets skyrocketed by 91bps in 2023 and then crashed by 146bps in 2024.
- Over the past 4 years, Amylyx Pharmaceuticals' Return on Assets (Quarterly) stood at -0.70% in 2022, then soared by 80bps to 0.10% in 2023, then slumped by 146bps to -1.36% in 2024, then surged by 36bps to -0.53% in 2025.
- Its Return on Assets stands at -0.53% for Q3 2025, versus -0.90% for Q2 2025 and -1.06% for Q1 2025.